-
The Daily Biotech Pulse: FDA Approves Bristol Myers' Oral Heart Disease Drug, European Approval For Merck's Keytruda, Genocea Restructures, Zymeworks' Takeover Bid
29 Apr 2022 13:25 GMT
… Benzinga's FDA Calendar.
Genocea Biosciences Inc GNCA is exploring strategic … disorder (ADHD) in adult patients.
IPOs
Belite Bio Inc BLTE
Hillevax …
-
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
24 Oct 2021 16:24 GMT
… TMO) (before the market open)
Genocea Biosciences, Inc. (NASDAQ: GNCA) ( … (before the market open)
IPOs
IPO Pricing
Princeton, New Jersey-based … million shares in an IPO. The Marlborough, Massachusetts- … "CDLA."
IPO Quiet Period Expiry
Exscientia …
-
The Daily Biotech Pulse: Mixed Tidings From Novavax, Radius Health Out-licenses Breast Cancer Drug, 3 IPOs
24 Jul 2020 11:43 GMT
… Genetics Inc (NASDAQ: FLGT)
Genocea Biosciences Inc (NASDAQ: GNCA) (reacted … estimates.
On The Radar
IPOs
iTeos Therapeutics, a clinical … patients, priced its initial public offering, or IPO, of 10.586 … , priced its upsized IPO of 7 million shares …
-
The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO
28 Feb 2020 12:42 GMT
… )
GenMark Diagnostics, Inc (NASDAQ: GNMK)
Genocea Biosciences Inc (NASDAQ: GNCA)
Geron Corporation … : GLYC) (before the market open)
IPO
Passage Bio, a biotech developing …
-
The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO
13 Feb 2020 13:22 GMT
… : EVLO) (before the market open)
Genocea Biosciences Inc (NASDAQ: GNCA) (before the … . (NYSE: BIO) (after the close)
IPOs
Revolution Medicines, a biotech developing …
-
The Daily Biotech Pulse: Opko Settles With SEC, Obalon Inks Financing Deals, Harpoon Files For IPO
28 Dec 2018 20:00 GMT
… • Capricor Therapeutics Inc (NASDAQ: CAPR)
• Genocea Biosciences Inc (NASDAQ: GNCA)
• Histogenics Corp … trading.
Harpoon Therapeutics Files For IPO
Harpoon Therapeutics, an immunotherapy … with the SEC regarding an initial public offering of its common stock. …
-
Gritstone Oncology IPO: Data To Be Released In 2019
08 Oct 2018 13:12 GMT
… working with Gritstone in this IPO are quite large, which … .
Balance Sheet Before The IPO: Beneficial Financial Shape With … share. Source: ADXS’s Website Genocea Biosciences (GNCA) trades at more … a pharmaceutical company executing an IPO. The float is large, …
-
Your Daily Pharma Scoop: Recent IPO And Offerings Review
31 May 2018 08:44 GMT
… ’t generally invest in IPOs. However, an IPO is also an opportunity … Therapeutics has filed for an initial public offering with an initial registration for … and plantar warts.
Secondary Offering Genocea Biosciences (NASDAQ:GNCA) has filed a …
-
Genocea: Investment Update On ~$6 Biotech 'Busted IPO'
01 Jun 2017 03:00 GMT
… a look below. Company Overview: Genocea Biosciences (NASDAQ: GNCA) is a … half the price of its IPO.
The company's … individuals against healthy subjects, Genocea selects the antigens with the … outbreaks within one year.
Genocea completed a dose optimization …
-
Bruised investors focus on biotechs with drugs closer to market
27 Jun 2022 11:42 GMT
… a senior data analyst at initial public offering (IPO) research firm Renaissance Capital, said … were a record 152 biotech IPOs globally, with companies raising … challenges our industry faces".
Genocea Biosciences, meanwhile, wound down its operations …